Processing

Please wait...

Settings

Settings

1. WO2012042128 - PHARMACEUTICAL COMPOSITION COMPRISING MEMANTINE AND VITAMIN D FOR TREATING ALZHEIMER'S DISEASE

Publication Number WO/2012/042128
Publication Date 05.04.2012
International Application No. PCT/FR2011/000528
International Filing Date 27.09.2011
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
59
Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
28
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61K 31/13 (2006.01)
A61K 31/59 (2006.01)
A61P 25/28 (2006.01)
CPC
A61K 31/13
A61K 31/59
A61K 31/593
A61K 45/06
A61K 47/10
A61K 9/0095
Applicants
  • LASNIER, Sébastien [FR/FR]; FR
Inventors
  • LASNIER, Sébastien; FR
Agents
  • PLACAIS, Jean-Yves; Cabinet Netter 36 avenue Hoche F-75008 Paris, FR
Priority Data
10/0385929.09.2010FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION COMPRISING MEMANTINE AND VITAMIN D FOR TREATING ALZHEIMER'S DISEASE
(FR) COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA MEMANTINE ET DE LA VITAMINE D POUR LE TRAITEMENT DE LA MALADIE D 1 ALZHEIMER
Abstract
(EN)
The invention relates to a pharmaceutical composition comprising the combination of the following two active ingredients: memantine or a pharmaceutically acceptable salt thereof, and at least one vitamin D. This composition is of use in the preparation of a medicament intended for the symptomatic treatment of Alzheimer's disease.
(FR)
L'invention concerne une composition pharmaceutique, comprenant l'association des deux principes actifs suivants; la mémantine ou un de ses sels pharmaceutiquement acceptables, et au moins une vitamine D. Cette composition est utile dans la préparation d'un médicament destiné au traitement symptomatique de la maladie d'Alzheimer.
Latest bibliographic data on file with the International Bureau